Concepedia

Masanobu Yasuda

MY

Statistics

Publications

3

Citations

140

H-Index

3

Active since

2017

Affiliations

Bayer (Germany)(Current)

Bayer (Japan)

St. Luke's International Hospital

Tottori University

Masanobu Yasuda is an author at Bayer (Germany) specializing in open-label trials, pharmacotherapy, and pharmacology.

Publications per year

2017–2017

3

Publications

3

Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial

Tasuku Harada, Saori Kosaka, J. Elliesen et al. · Fertility and Sterility · 2017 · 84 citations · Full text

, , +11

Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer

Nobuaki Matsubara, Hirofumi Mukai, Ako Hosono et al. · Cancer Chemotherapy and Pharmacology · 2017 · 33 citations · Full text

, , +17

Efficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled study

Mikio Momoeda, Masami Kondo, Jörg Elliesen et al. · International Journal of Women s Health · 2017 · 23 citations · Full text

, , +17

1–3 of 3